Preventing future acute coronary events: Is the target the so-called vulnerable plaque or the high-risk or vulnerable patient?

Current Opinion in Cardiology

Volumn 24, Issue 5, 2009, Pages 483-489

  Ambrose, John A ^a   Srikanth, Sundararajan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary disease; Myocardial infarction; Primary prevention; Risk factors; Vulnerable plaque

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; OMEGA 3 FATTY ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; ROSUVASTATIN; TROPONIN I; WARFARIN; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CARDIAC PATIENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED MEDICINE; GENETIC ANALYSIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INVASIVE PROCEDURE; LIFESTYLE MODIFICATION; MOLECULAR IMAGING; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; POSITRON EMISSION TOMOGRAPHY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SCORING SYSTEM; SCREENING; SECONDARY PREVENTION; SINGLE NUCLEOTIDE POLYMORPHISM; ST SEGMENT ELEVATION; ACUTE DISEASE; CORONARY ARTERY DISEASE; RISK FACTOR;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; HUMANS; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION;

EID: 69749083699     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32832ec379     Document Type: Review

References (42)

1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics: 2007 update - a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69-e171.
2. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356:2388-2398.
3. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47 (8 Suppl):C13-C18.
4. Ambrose JA, Tannenbaum MA, Alexopoulos B, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12:56-62. (Pubitemid 18158024)
5. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild to moderate coronary artery disease? Circulation 1988; 78:1157-1166.
6. Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000; 35:106-111. (Pubitemid 30061267)
7. Brown BG, Gallery RS, Badger RS, et al. Incomplete lysis of thrombus in the moderate underlying atherosclerosis lesion during intracoronary infusion of streptokinase for acute myocardial infarction. Circulation 1986; 73:653-661.
8. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12:56-62. (Pubitemid 18158024)
9. Schaar JA, Muller JE, Falk E, et al. Terminology for high-risk and vulnerable coronary artery plaques. Eur Heart J 2004; 25:1077-1082. (Pubitemid 38869428)
10. Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000; 83:361-366.
11. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93:1354-1363. (Pubitemid 26099346)
12. Wang JC, Normand SL, Mauri L, Kuntz RE. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 2004; 110:278-284. (Pubitemid 38960797)
13. Schoenhagen P, Zinda KM, Kapadia SR, et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndrome: an intravascular ultrasound study. Circulation 2000; 101:604-610. (Pubitemid 30094729)
14. Ambrose JA. In search of the 'vulnerable plaque'. Can it be localized and will focal regional therapy ever be an option for cardiac prevention? J Am Coll Cardiol 2008; 51:1539-1542. The author's review of the concept of vulnerable plaque that not only discusses strategies to identify a vulnerable plaque but also its associated pitfalls.
15. Maseri A, Fuster V. Is there a vulnerable plaque? Circulation 2003; 107:2068-2071.
16. Libby P. Act local, act global: inflammation and the multiplicity of 'vulnerable' coronary plaques. J Am Coll Cardiol 2005; 45:1600-1602.
17. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient. Circulation 2003; 108:1664-1672.
18. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
19. Khot UN, Khot MB, Baizer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290:898-904. (Pubitemid 37430461)
20. Akosah KO, Schaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 2003; 41:1480-1481.
21. Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006; 92:1752-1759. (Pubitemid 44851316)
22. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007; 335:136-148. (Pubitemid 47172233)
23. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to the cardiovascular risk assessment: the ASSIGN score form the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 2:172-176. (Pubitemid 46180289)
24. Ambrose JA, D'Agate D. Classification of systemic therapies for potential stabilization of the vulnerable plaque to prevent acute myocardial infarction. Am J Cardiol 2005; 95:379-382. (Pubitemid 40164543)
25. Smith SC Jr, Allen J, Blair SN, et al., AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - endorsed by the National Heart. Lung and Blood Institute. Circulation 2006; 113:2363-2372.
26. Marchioli R, Barzi F, Bomba E, et al., GISSI-Prevensione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Dopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105:1897-1903.
27. Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation 2006; 114:1549-1553. (Pubitemid 44527011)
28. Hurlen M, Abdelnoor M, Smith P, et al. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002; 347:969-974.
29. Zalewski A, Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology and possible therapeutic target. Arterioslcer Thromb Vasc Biol 2005; 25:923-931. (Pubitemid 40627835)
30. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007; 49:2129-2138.
31. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355:2631-2639.
32. Pearson TA, Mensah GA, Alexander RW, et al. Centers for Disease Control and Prevention: American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107:499-511.
33. Ridker PM, Danielson E, Fonseca FAH, et al., for the JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:2195-2207. A randomized controlled trial that expands the envelope of primary prevention of cardiovascular disease.
34. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women. The Reynolds Risk Score. JAMA 2007; 297:611-619. (Pubitemid 46257283)
35. Davies JR, Rudd JH, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 2006; 47:C57-C68.
36. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330:1041-1046. (Pubitemid 24106561)
37. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347:1916-1923. (Pubitemid 35429921)
38. Topol EJ. The genetics of heart attack. Heart 2006; 92:855-861.
39. Topol EJ. The genomic basis of myocardial infarction. J Am Coll Cardiol 2005; 46:1456-1465.
40. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient: part III - executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) task force report. Am J Cardiol 2006; 98 (Suppl):2H-15H. (Pubitemid 44523760)
41. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358:1336-1345. Coronary calcium score is shown to be a strong predictor of CAD and provides predictive information beyond that provided by traditional risk factors.
42. Lakoske SG, Greenland P, Wong N, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as 'low risk' based on Framingham Risk Score. Arch Intern Med 2007; 167:2437-2442.